Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerken

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Transplantation Proceedings|November 18, 2008
Incidence of liver retransplantation and its effect on patient survivalH Lang, G C Sotiropoulos, S Beckebaum, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|February 3, 2016
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infectionR Broering, M Trippler, M Werner, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 2, 2021
Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adultsA Figge, S Sydor, C Wenning, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)H L Janssen, G Gerken, V Carreño, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2013
[Diagnosis of and therapy for hepatocellular carcinoma]T F Greten, N P Malek, S Schmidt, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Transplantation Proceedings|November 18, 2008
Incidence of liver retransplantation and its effect on patient survivalH Lang, G C Sotiropoulos, S Beckebaum, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|February 3, 2016
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infectionR Broering, M Trippler, M Werner, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 2, 2021
Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adultsA Figge, S Sydor, C Wenning, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)H L Janssen, G Gerken, V Carreño, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2013
[Diagnosis of and therapy for hepatocellular carcinoma]T F Greten, N P Malek, S Schmidt, et al.
Pageof 31